Avails Medical has developed digital technology to provide accurate, rapid detection of infections in any bodily fluid while indicating real-time which drugs are most effective. For decades, lab technicians have detected infections through crude, time-consuming, error-ridden techniques of dipsticks and specimen sampling, leaving physicians to guess which antibiotic might be effective since reliable results take days to develop. Avails' electronic biosensor technology improves accuracy in detecting infections and provides critical, timely information regarding antibiotic sensitivity and resistance. Avails' cost-effective platform will transform the diagnostics market by enabling for the first time diagnostic-guided therapy at the point-of-care, reducing time-to-treatment from days to minutes.